Olmesartan/amlodipine/hydrochlorothiazide in participants with hypertension and diabetes, chronic kidney disease, or chronic cardiovascular disease: a subanalysis of the multicenter, randomized, double-blind, parallel-group TRINITY study

Olmesartan/amlodipine/hydrochlorothiazide in participants with hypertension and diabetes, chronic kidney disease, or chronic cardiovascular disease: a subanalysis of the multicenter, randomized, double-blind, parallel-group TRINITY study

<p>Abstract</p> <p>Background</p> <p>Patients with hypertension and cardiovascular disease (CVD), diabetes, or chronic kidney disease (CKD) usually require two or more antihypertensive agents to achieve blood pressure (BP) goals.</p> <p>Methods</p> <...

Full description

Bibliographic Details
Main Authors: Kereiakes Dean J, Chrysant Steven G, Izzo Joseph L, Littlejohn Thomas, Melino Michael, Lee James, Fernandez Victor, Heyrman Reinilde
Format: Article
Language:English
Published: BMC 2012-10-01
Series:Cardiovascular Diabetology
Subjects:
Hypertension
Diabetes mellitus
Chronic kidney disease
Cardiovascular diseases
Drug combinations
Online Access:http://www.cardiab.com/content/11/1/134

Internet

http://www.cardiab.com/content/11/1/134

Similar Items